These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19192468)

  • 1. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.
    Zisook S; Kasckow JW; Golshan S; Fellows I; Solorzano E; Lehman D; Mohamed S; Jeste DV
    J Clin Psychiatry; 2009 Apr; 70(4):562-71. PubMed ID: 19192468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
    Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
    J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression?
    Dawes SE; Palmer BW; Meeks T; Golshan S; Kasckow J; Mohamed S; Zisook S
    Neuropsychobiology; 2012; 65(3):168-72. PubMed ID: 22456094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.
    Kasckow J; Fellows I; Golshan S; Solorzano E; Meeks T; Zisook S
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):853-7. PubMed ID: 20808103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms.
    Vahia IV; Lanouette NM; Golshan S; Fellows I; Mohamed S; Kasckow JW; Zisook S
    Indian J Psychiatry; 2013 Apr; 55(2):144-8. PubMed ID: 23825848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia.
    Zisook S; Montross L; Kasckow J; Mohamed S; Palmer BW; Patterson TL; Golshan S; Fellows I; Lehman D; Solorzano E
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1005-14. PubMed ID: 18056819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A; Ratner Y; Ritsner MS
    Clin Schizophr Relat Psychoses; 2018; 12(1):31-41. PubMed ID: 26218236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurring depressive symptoms in the older patient with schizophrenia.
    Kasckow JW; Zisook S
    Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
    JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
    Nasib LG; Sommer IE; Winter-van Rossum I; de Vries J; Gangadin SS; Oomen PP; Judge G; Blom RE; Luykx JJ; van Beveren NJM; Veen ND; Kroken RA; Johnsen EL
    Trials; 2020 Jun; 21(1):492. PubMed ID: 32513294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram augmentation of antipsychotic treatment in older schizophrenia patients.
    Kasckow JW; Mohamed S; Thallasinos A; Carroll B; Zisook S; Jeste DV
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1163-7. PubMed ID: 11748776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram in first episode schizophrenia: The DECIFER trial.
    Goff DC; Freudenreich O; Cather C; Holt D; Bello I; Diminich E; Tang Y; Ardekani BA; Worthington M; Zeng B; Wu R; Fan X; Li C; Troxel A; Wang J; Zhao J
    Schizophr Res; 2019 Jun; 208():331-337. PubMed ID: 30709746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.